Description
LETROZOLE 2.5 mg is used as adjuvant treatment for hormone receptor-positive breast cancer in postmenopausal women. It lowers estrogen production by inhibiting the aromatase enzyme, slowing tumor growth.
LETROZOLE 2.5 mg is used as adjuvant treatment for hormone receptor-positive breast cancer in postmenopausal women. It lowers estrogen production by inhibiting the aromatase enzyme, slowing tumor growth.
Reviews
There are no reviews yet.